{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T18:17:18Z","timestamp":1787595438363,"version":"build-2736575974"},"reference-count":189,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T00:00:00Z","timestamp":1722124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Neurotrophins are important regulators of neuronal and non-neuronal functions. As such, the neurotrophins and their receptors, the tropomyosin receptor kinase (Trk) family of receptor tyrosine kinases, has attracted intense research interest and their role in multiple diseases including Alzheimer\u2019s disease has been described. Attempts to administer neurotrophins to patients have been reported, but the clinical trials have so far have been hampered by side effects or a lack of clear efficacy. Thus, much of the focus during recent years has been on identifying small molecules acting as agonists or positive allosteric modulators (PAMs) of Trk receptors. Two examples of successful discovery and development of PAMs are the TrkA-PAM E2511 and the pan-Trk PAM ACD856. E2511 has been reported to have disease-modifying effects in preclinical models, whereas ACD856 demonstrates both a symptomatic and a disease-modifying effect in preclinical models. Both molecules have reached the stage of clinical development and were reported to be safe and well tolerated in clinical phase 1 studies, albeit with different pharmacokinetic profiles. These two emerging small molecules are interesting examples of possible novel symptomatic and disease-modifying treatments that could complement the existing anti-amyloid monoclonal antibodies for the treatment of Alzheimer\u2019s disease. This review aims to present the concept of positive allosteric modulators of the Trk receptors as a novel future treatment option for Alzheimer\u2019s disease and other neurodegenerative and cognitive disorders, and the current preclinical and clinical data supporting this new concept. Preclinical data indicate dual mechanisms, not only as cognitive enhancers, but also a tentative neurorestorative function.<\/jats:p>","DOI":"10.3390\/ph17080997","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T15:26:53Z","timestamp":1722526013000},"page":"997","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Positive Allosteric Modulators of Trk Receptors for the Treatment of Alzheimer\u2019s Disease"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8384-1547","authenticated-orcid":false,"given":"Pontus","family":"Forsell","sequence":"first","affiliation":[{"name":"AlzeCure Pharma AB, H\u00e4lsov\u00e4gen 7, 141 57 Huddinge, Sweden"},{"name":"Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Alfred Nobels all\u00e9 23, 141 52 Huddinge, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Parrado Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"AlzeCure Pharma AB, H\u00e4lsov\u00e4gen 7, 141 57 Huddinge, Sweden"},{"name":"Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Alfred Nobels all\u00e9 23, 141 52 Huddinge, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boel","family":"Nilsson","sequence":"additional","affiliation":[{"name":"AlzeCure Pharma AB, H\u00e4lsov\u00e4gen 7, 141 57 Huddinge, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Sandin","sequence":"additional","affiliation":[{"name":"AlzeCure Pharma AB, H\u00e4lsov\u00e4gen 7, 141 57 Huddinge, Sweden"},{"name":"Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Alfred Nobels all\u00e9 23, 141 52 Huddinge, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Nordvall","sequence":"additional","affiliation":[{"name":"AlzeCure Pharma AB, H\u00e4lsov\u00e4gen 7, 141 57 Huddinge, Sweden"},{"name":"Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Alfred Nobels all\u00e9 23, 141 52 Huddinge, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e4rta","family":"Segerdahl","sequence":"additional","affiliation":[{"name":"AlzeCure Pharma AB, H\u00e4lsov\u00e4gen 7, 141 57 Huddinge, Sweden"},{"name":"Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Alfred Nobels all\u00e9 23, 141 52 Huddinge, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,7,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","article-title":"Donanemab in Early Alzheimer\u2019s Disease","volume":"384","author":"Mintun","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_2","first-page":"9","article-title":"Lecanemab in Early Alzheimer\u2019s Disease","volume":"388","author":"Swanson","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s13195-022-01129-x","article-title":"Consistency of Efficacy Results across Various Clinical Measures and Statistical Methods in the Lecanemab Phase 2 Trial of Early Alzheimer\u2019s Disease","volume":"14","author":"Dhadda","year":"2022","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s13195-022-01124-2","article-title":"Lecanemab in Patients with Early Alzheimer\u2019s Disease: Detailed Results on Biomarker, Cognitive, and Clinical Effects from the Randomized and Open-Label Extension of the Phase 2 Proof-of-Concept Study","volume":"14","author":"McDade","year":"2022","journal-title":"Alzheimers Res. Ther."},{"key":"ref_5","first-page":"595","article-title":"\u201cTime Saved\u201d As a Demonstration of Clinical Meaningfulness and Illustrated Using the Donanemab TRAILBLAZER-ALZ Study Findings","volume":"10","author":"Dickson","year":"2023","journal-title":"J. Prev. Alzheimers Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1749-6632.1952.tb26548.x","article-title":"Effects of Mouse Tumor Transplantation on the Nervous System","volume":"55","year":"1952","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/303821a0","article-title":"Human \u03b2-Nerve Growth Factor Gene Sequence Highly Homologous to That of Mouse","volume":"303","author":"Ullrich","year":"1983","journal-title":"Nature"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/302538a0","article-title":"Isolation and Nucleotide Sequence of a CDNA Encoding the Precursor of Mouse Nerve Growth Factor","volume":"302","author":"Scott","year":"1983","journal-title":"Nature"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/j.1460-2075.1982.tb01207.x","article-title":"Purification of a New Neurotrophic Factor from Mammalian Brain","volume":"1","author":"Barde","year":"1982","journal-title":"EMBO J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"5454","DOI":"10.1073\/pnas.87.14.5454","article-title":"Molecular Cloning and Neurotrophic Activities of a Protein with Structural Similarities to Nerve Growth Factor: Developmental and Topographical Expression in the Brain","volume":"87","author":"Ernfors","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"8060","DOI":"10.1073\/pnas.87.20.8060","article-title":"Molecular Cloning of a Human Gene That Is a Member of the Nerve Growth Factor Family","volume":"87","author":"Jones","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/344339a0","article-title":"Identification and Characterization of a Novel Member of the Nerve Growth Factor\/Brain-Derived Neurotrophic Factor Family","volume":"344","author":"Hohn","year":"1990","journal-title":"Nature"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/0896-6273(91)90287-A","article-title":"Neurotrophin-5: A Novel Neurotrophic Factor That Activates Trk and TrkB","volume":"7","author":"Berkemeier","year":"1991","journal-title":"Neuron"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/0896-6273(91)90180-8","article-title":"Evolutionary Studies of the Nerve Growth Factor Family Reveal a Novel Member Abundantly Expressed in Xenopus Ovary","volume":"6","author":"Persson","year":"1991","journal-title":"Neuron"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1073\/pnas.89.7.3060","article-title":"Mammalian Neurotrophin-4: Structure, Chromosomal Localization, Tissue Distribution, and Receptor Specificity","volume":"89","author":"Ip","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0092-8674(91)90419-Y","article-title":"The Trk Proto-Oncogene Encodes a Receptor for Nerve Growth Factor","volume":"65","author":"Klein","year":"1991","journal-title":"Cell"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0092-8674(91)90628-C","article-title":"The TrkB Tyrosine Protein Kinase Is a Receptor for Brain-Derived Neurotrophic Factor and Neurotrophin-3","volume":"66","author":"Klein","year":"1991","journal-title":"Cell"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1006\/geno.1994.1383","article-title":"Molecular Cloning of the CDNA for Human TrkC (NTRK3), Chromosomal Assignment, and Evidence for a Splice Variant","volume":"22","author":"McGregor","year":"1994","journal-title":"Genomics"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/neu.480251106","article-title":"The P75 Neurotrophin Receptor","volume":"25","author":"Chao","year":"1994","journal-title":"J. Neurobiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2007.01.021","article-title":"Molecular Evolution of the Neurotrophin Family Members and Their Trk Receptors","volume":"394","author":"Lanave","year":"2007","journal-title":"Gene"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000094083","article-title":"Formation and Evolution of the Chordate Neurotrophin and Trk Receptor Genes","volume":"68","author":"Wilson","year":"2006","journal-title":"Brain Behav. Evol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Zhu, B., Pennack, J.A., McQuilton, P., Forero, M.G., Mizuguchi, K., Sutcliffe, B., Gu, C.J., Fenton, J.C., and Hidalgo, A. (2008). Drosophila Neurotrophins Reveal a Common Mechanism for Nervous System Formation. PLoS Biol., 6.","DOI":"10.4016\/8389.01"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/cne.903500407","article-title":"TrkA-Immunoreactive Profiles in the Central Nervous System: Colocalization with Neurons Containing P75 Nerve Growth Factor Receptor, Choline Acetyltransferase, and Serotonin","volume":"350","author":"Sobreviela","year":"1994","journal-title":"J. Comp. Neurol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1523\/JNEUROSCI.15-02-01567.1995","article-title":"TrkA Expression in the CNS: Evidence for the Existence of Several Novel NGF-Responsive CNS Neurons","volume":"15","author":"Holtzman","year":"1995","journal-title":"J. Neurosci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/cne.903560306","article-title":"Expression of Trk Receptors in the Developing and Adult Human Central and Peripheral Nervous System","volume":"356","author":"Muragaki","year":"1995","journal-title":"J. Comp. Neurol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/cne.1380","article-title":"GDNF and NGF Family Members and Receptors in Human Fetal and Adult Spinal Cord and Dorsal Root Ganglia","volume":"440","author":"Josephson","year":"2001","journal-title":"J. Comp. Neurol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/ar.1092400415","article-title":"Immunohistochemical Localization of the High-Affinity NGF Receptor (Gp 140-TrkA) in the Adult Human Dorsal Root and Sympathetic Ganglia and in the Nerves and Sensory Corpuscles Supplying Digital Skin","volume":"240","author":"Vega","year":"1994","journal-title":"Anat. Rec."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.tips.2021.06.006","article-title":"In Vivo Functions of P75NTR: Challenges and Opportunities for an Emerging Therapeutic Target","volume":"42","author":"Malik","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e23312","DOI":"10.1096\/fj.202301140RR","article-title":"Upregulation of ProBDNF\/P75NTR Signaling in Immune Cells and Its Correlation with Inflammatory Markers in Patients with Major Depression","volume":"38","author":"Yang","year":"2024","journal-title":"FASEB J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1038\/s41467-024-47633-6","article-title":"Nerve Growth Factor Receptor Limits Inflammation to Promote Remodeling and Repair of Osteoarthritic Joints","volume":"15","author":"Zhao","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1469-7580.2003.00203.x","article-title":"Neurotrophins and the Immune System","volume":"203","author":"Vega","year":"2003","journal-title":"J. Anat."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Minnone, G., Benedetti, F.D., and Bracci-Laudiero, L. (2017). NGF and Its Receptors in the Regulation of Inflammatory Response. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18051028"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1017\/S0317167100032935","article-title":"Neurotrophin Regulation of Gene Expression","volume":"24","author":"Bonni","year":"1997","journal-title":"Can. J. Neurol. Sci. J. Can. Des Sci. Neurol."},{"key":"ref_34","first-page":"135","article-title":"Nerve Growth Factor Regulates Gene Expression by Several Distinct Mechanisms","volume":"9","author":"Cho","year":"1989","journal-title":"Mol. Cell. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"16606","DOI":"10.1074\/jbc.M113.475285","article-title":"Dissecting the Roles of Tyrosines 490 and 785 of TrkA Protein in the Induction of Downstream Protein Phosphorylation Using Chimeric Receptors","volume":"288","author":"Biarc","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/bies.20118","article-title":"From Modulator to Mediator: Rapid Effects of BDNF on Ion Channels","volume":"26","author":"Rose","year":"2004","journal-title":"BioEssays"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1113\/jphysiol.2003.039990","article-title":"Signalling Pathways Involved in the Sensitisation of Mouse Nociceptive Neurones by Nerve Growth Factor","volume":"551","author":"Bonnington","year":"2003","journal-title":"J. Physiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1006\/mcne.1997.0656","article-title":"Neurotrophins Differentially Regulate Voltage-Gated Ion Channels","volume":"10","author":"Lesser","year":"1997","journal-title":"Mol. Cell Neurosci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2174\/157015911798376190","article-title":"The Neurotrophins and Their Role in Alzheimer\u2019s Disease","volume":"9","author":"Allen","year":"2011","journal-title":"Curr. Neuropharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Castr\u00e9n, E. (2014). Neurotrophins and Psychiatric Disorders. Neurotrophic Factors, Springer.","DOI":"10.1007\/978-3-642-45106-5_17"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/FBP.0b013e32833d8bc9","article-title":"Brain-Derived Neurotrophic Factor in Traumatic Brain Injury, Post-Traumatic Stress Disorder, and Their Comorbid Conditions: Role in Pathogenesis and Treatment","volume":"21","author":"Kaplan","year":"2010","journal-title":"Behav. Pharmacol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1515\/hsz-2016-0280","article-title":"\u03b2-NGF and \u03b2-NGF Receptor Upregulation in Blood and Synovial Fluid in Osteoarthritis","volume":"398","author":"Montagnoli","year":"2017","journal-title":"Biol. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/00001756-199305000-00025","article-title":"Increased Levels of NGF in Sera of Systemic Lupus Erythematosus Patients","volume":"4","author":"Aloe","year":"1993","journal-title":"NeuroReport"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0304-3940(92)90762-V","article-title":"Multiple Sclerosis Patients Express Increased Levels of \u03b2-Nerve Growth Factor in Cerebrospinal Fluid","volume":"147","author":"Laudiero","year":"1992","journal-title":"Neurosci. Lett."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"10955","DOI":"10.1073\/pnas.93.20.10955","article-title":"Circulating Nerve Growth Factor Levels Are Increased in Humans with Allergic Diseases and Asthma","volume":"93","author":"Bonini","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0092-8674(03)00035-7","article-title":"The BDNF Val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal Function","volume":"112","author":"Egan","year":"2003","journal-title":"Cell"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"6690","DOI":"10.1523\/JNEUROSCI.23-17-06690.2003","article-title":"Brain-Derived Neurotrophic Factor Val66met Polymorphism Affects Human Memory-Related Hippocampal Activity and Predicts Memory Performance","volume":"23","author":"Hariri","year":"2003","journal-title":"J. Neurosci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1212\/WNL.0000000000003980","article-title":"BDNF Val66Met Predicts Cognitive Decline in the Wisconsin Registry for Alzheimer\u2019s Prevention","volume":"88","author":"Boots","year":"2017","journal-title":"Neurology"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Lim, Y., Villemagne, V.L., Laws, S.M., Ames, D., Pietrzak, R.H., Ellis, K.A., Harrington, K., Bourgeat, P., Bush, A.I., and Martins, R.N. (2014). Effect of BDNF Val66Met on Memory Decline and Hippocampal Atrophy in Prodromal Alzheimer\u2019s Disease: A Preliminary Study. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0086498"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/jamaneurol.2021.5181","article-title":"Association of BDNF Val66Met with Tau Hyperphosphorylation and Cognition in Dominantly Inherited Alzheimer Disease","volume":"79","author":"Lim","year":"2022","journal-title":"JAMA Neurol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.jagp.2016.08.007","article-title":"\u03b2-Amyloid, APOE and BDNF Genotype, and Depressive and Anxiety Symptoms in Cognitively Normal Older Women and Men","volume":"24","author":"Holmes","year":"2016","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1016\/j.neurobiolaging.2013.05.006","article-title":"BDNF Val66Met, A\u03b2 Amyloid, and Cognitive Decline in Preclinical Alzheimer\u2019s Disease","volume":"34","author":"Lim","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/s41380-019-0404-6","article-title":"The BDNF(Val66Met) SNP Modulates the Association between Beta-Amyloid and Hippocampal Disconnection in Alzheimer\u2019s Disease","volume":"26","author":"Franzmeier","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.bbr.2014.06.022","article-title":"APOE and BDNF Val66Met Polymorphisms Combine to Influence Episodic Memory Function in Older Adults","volume":"271","author":"Ward","year":"2014","journal-title":"Behav. Brain Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/mp.2014.123","article-title":"APOE and BDNF Polymorphisms Moderate Amyloid \u03b2-Related Cognitive Decline in Preclinical Alzheimer\u2019s Disease","volume":"20","author":"Lim","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3233\/JAD-200132","article-title":"Interaction Between BDNF Val66Met and APOE4 on Biomarkers of Alzheimer\u2019s Disease and Cognitive Decline","volume":"78","author":"Stonnington","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.brainres.2014.09.044","article-title":"BDNF Val66met Polymorphism Affects Aging of Multiple Types of Memory","volume":"1612","author":"Kennedy","year":"2015","journal-title":"Brain Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1590\/1516-4446-2017-3904","article-title":"BDNF Val66Met Polymorphism and Memory Performance in Older Adults: The Met Carrier Effect Is More Complex than Previously Thought: Authors\u2019 Reply","volume":"39","author":"Azeredo","year":"2017","journal-title":"Rev. Bras. Psiquiatr."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neurobiolaging.2023.10.009","article-title":"DAT1 and BDNF Polymorphisms Interact to Predict A\u03b2 and Tau Pathology","volume":"133","author":"Ciampa","year":"2024","journal-title":"Neurobiol. Aging"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000074636","article-title":"Association Study of a Brain-Derived Neurotrophic-Factor Genetic Polymorphism and Mood Disorders, Age of Onset and Suicidal Behavior","volume":"48","author":"Hong","year":"2003","journal-title":"Neuropsychobiology"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0896-6273(94)90223-2","article-title":"Trk Receptors Use Redundant Signal Transduction Pathways Involving SHC and PLC-\u03931 to Mediate NGF Responses","volume":"12","author":"Stephens","year":"1994","journal-title":"Neuron"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1432-1033.1995.084_c.x","article-title":"Phosphotyrosine Residues in the Nerve-Growth-Factor Receptor (Trk-A)","volume":"234","author":"Baxter","year":"1995","journal-title":"Eur. J. Biochem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"22963","DOI":"10.1016\/S0021-9258(19)49410-6","article-title":"Identification of Trk Binding Sites for SHC and Phosphatidylinositol 3\u2032-Kinase and Formation of a Multimeric Signaling Complex","volume":"268","author":"Obermeier","year":"1993","journal-title":"J. Biol. Chem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/nrn2738","article-title":"TrkB Signalling Pathways in LTP and Learning","volume":"10","author":"Minichiello","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1523\/JNEUROSCI.4294-13.2014","article-title":"TrkA in Vivo Function Is Negatively Regulated by Ubiquitination","volume":"34","author":"Kiris","year":"2014","journal-title":"J. Neurosci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.2147\/JPR.S247472","article-title":"Nerve Growth Factor Signaling and Its Contribution to Pain","volume":"13","author":"Barker","year":"2020","journal-title":"J. Pain. Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1126\/science.1065057","article-title":"Regulation of Cell Survival by Secreted Proneurotrophins","volume":"294","author":"Lee","year":"2001","journal-title":"Science"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Palasz, E., Wysocka, A., Gasiorowska, A., Chalimoniuk, M., Niewiadomski, W., and Niewiadomska, G. (2020). BDNF as a Promising Therapeutic Agent in Parkinson\u2019s Disease. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21031170"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1073\/pnas.73.7.2424","article-title":"Establishment of a Noradrenergic Clonal Line of Rat Adrenal Pheochromocytoma Cells Which Respond to Nerve Growth Factor","volume":"73","author":"Greene","year":"1976","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cell.2021.12.003","article-title":"BDNF Signaling in Context: From Synaptic Regulation to Psychiatric Disorders","volume":"185","author":"Wang","year":"2022","journal-title":"Cell"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/jnc.15945","article-title":"Brain-derived Neurotrophic Factor Protects Neurons by Stimulating Mitochondrial Function through Protein Kinase A","volume":"167","author":"Swain","year":"2023","journal-title":"J. Neurochem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1096\/fj.12-207316","article-title":"Structural and Functional Insights into Lipid-bound Nerve Growth Factors","volume":"26","author":"Tong","year":"2012","journal-title":"FASEB J."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1385\/JMN:14:1-2:069","article-title":"NGF Stimulation of Erk Phosphorylation Is Impaired by a Point Mutation in the Transmembrane Domain of TrkA Receptor","volume":"14","author":"Monshipouri","year":"2000","journal-title":"J. Mol. Neurosci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1074\/mcp.M111.013375","article-title":"The Induction of Serine\/Threonine Protein Phosphorylations by a PDGFR\/TrkA Chimera in Stably Transfected PC12 Cells","volume":"11","author":"Biarc","year":"2012","journal-title":"Mol. Cell Proteom."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1111\/j.1460-9568.1995.tb01102.x","article-title":"TrkA Tyrosine Residues Involved in NGF-induced Neurite Outgrowth of PC12 Cells","volume":"7","author":"Inagaki","year":"1995","journal-title":"Eur. J. Neurosci."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neures.2009.06.004","article-title":"Mechanisms, Locations, and Kinetics of Synaptic BDNF Secretion: An Update","volume":"65","author":"Brigadski","year":"2009","journal-title":"Neurosci. Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1002\/j.1460-2075.1991.tb07778.x","article-title":"Two Conserved Domains in the NGF Propeptide Are Necessary and Sufficient for the Biosynthesis of Correctly Processed and Biologically Active NGF","volume":"10","author":"Suter","year":"1991","journal-title":"EMBO J."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"306","DOI":"10.17712\/nsj.2016.4.20160080","article-title":"Mechanisms and Regulation of Neurotrophin Synthesis and Secretion","volume":"21","year":"2016","journal-title":"Neurosciences"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1042\/bj3140951","article-title":"Cellular Processing of the Nerve Growth Factor Precursor by the Mammalian Pro-Protein Convertases","volume":"314","author":"Seidah","year":"1996","journal-title":"Biochem. J."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"6735","DOI":"10.1073\/pnas.0510645103","article-title":"Activity-Dependent Release of Precursor Nerve Growth Factor, Conversion to Mature Nerve Growth Factor, and Its Degradation by a Protease Cascade","volume":"103","author":"Bruno","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Xue, B., Waseem, S.M.A., Zhu, Z., Alshahrani, M.A., Nazam, N., Anjum, F., Habib, A.H., Rafeeq, M.M., Nazam, F., and Sharma, M. (2022). Brain-Derived Neurotrophic Factor: A Connecting Link Between Nutrition, Lifestyle, and Alzheimer\u2019s Disease. Front. Neurosci., 16.","DOI":"10.3389\/fnins.2022.925991"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"101580","DOI":"10.1016\/j.eclinm.2022.101580","article-title":"Global and Regional Projections of the Economic Burden of Alzheimer\u2019s Disease and Related Dementias from 2019 to 2050: A Value of Statistical Life Approach","volume":"51","author":"Nandi","year":"2022","journal-title":"eClinicalMedicine"},{"key":"ref_83","first-page":"152","article-title":"Non-Amyloid Approaches to Disease Modification for Alzheimer\u2019s Disease: An EU\/US CTAD Task Force Report","volume":"7","author":"Gauthier","year":"2020","journal-title":"J. Prev. Alzheimer\u2019s Dis."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0896-6273(92)90284-K","article-title":"Selective Dependence of Mammalian Dorsal Root Ganglion Neurons on Nerve Growth Factor during Embryonic Development","volume":"8","author":"Ruit","year":"1992","journal-title":"Neuron"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/368246a0","article-title":"Severe Sensory and Sympathetic Neuropathies in Mice Carrying a Disrupted Trk\/NGF Receptor Gene","volume":"368","author":"Smeyne","year":"1994","journal-title":"Nature"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/0092-8674(94)90378-6","article-title":"Mice Lacking Nerve Growth Factor Display Perinatal Loss of Sensory and Sympathetic Neurons yet Develop Basal Forebrain Cholinergic Neurons","volume":"76","author":"Crowley","year":"1994","journal-title":"Cell"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0092-8674(05)80088-1","article-title":"Targeted Disruption of the TrkB Neurotrophin Receptor Gene Results in Nervous System Lesions and Neonatal Death","volume":"75","author":"Klein","year":"1993","journal-title":"Cell"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/368147a0","article-title":"Mice Lacking Brain-Derived Neurotrophic Factor Develop with Sensory Deficits","volume":"368","author":"Ernfors","year":"1994","journal-title":"Nature"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1111\/j.1460-9568.1997.tb01687.x","article-title":"Learning Deficit in BDNF Mutant Mice","volume":"9","author":"Linnarsson","year":"1997","journal-title":"Eur. J. Neurosci."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1101\/lm.028068.112","article-title":"Age-Dependent Deficits in Fear Learning in Heterozygous BDNF Knock-out Mice","volume":"19","author":"Endres","year":"2012","journal-title":"Learn. Mem."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neulet.2007.12.035","article-title":"Characterization of Sensory Deficits in TrkB Knockout Mice","volume":"433","author":"Cobo","year":"2008","journal-title":"Neurosci. Lett."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.1523\/JNEUROSCI.16-17-05361.1996","article-title":"Mice Lacking Brain-Derived Neurotrophic Factor Exhibit Visceral Sensory Neuron Losses Distinct from Mice Lacking NT4 and Display a Severe Developmental Deficit in Control of Breathing","volume":"16","author":"Erickson","year":"1996","journal-title":"J. Neurosci."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1210\/mend.15.10.0706","article-title":"Conditional Deletion Of Brain-Derived Neurotrophic Factor in the Postnatal Brain Leads to Obesity and Hyperactivity","volume":"15","author":"Rios","year":"2001","journal-title":"Mol. Endocrinol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/nn1336","article-title":"A de Novo Mutation Affecting Human TrkB Associated with Severe Obesity and Developmental Delay","volume":"7","author":"Yeo","year":"2004","journal-title":"Nat. Neurosci."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1203\/00006450-199904020-00253","article-title":"Reduction of Brain Derived Neurotrophic Factor Causes Obesity and Hyperactivity: Implications for WAGR Syndrome","volume":"45","author":"Kernie","year":"1999","journal-title":"Pediatr. Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"105392","DOI":"10.1016\/j.psyneuen.2021.105392","article-title":"Association between the Improvement in Depressive Symptoms and Serum BDNF Levels in Drug-Naive First Episode Patients with Schizophrenia: A Longitudinal Follow-Up","volume":"133","author":"Han","year":"2021","journal-title":"Psychoneuroendocrinology"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"6208","DOI":"10.1523\/JNEUROSCI.16-19-06208.1996","article-title":"TrkA, but Not TrkC, Receptors Are Essential for Survival of Sympathetic Neurons in Vivo","volume":"16","author":"Fagan","year":"1996","journal-title":"J. Neurosci."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/368249a0","article-title":"Disruption of the Neurotrophin-3 Receptor Gene TrkC Eliminates La Muscle Afferents and Results in Abnormal Movements","volume":"368","author":"Klein","year":"1994","journal-title":"Nature"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/(SICI)1098-1136(199904)26:2<153::AID-GLIA6>3.0.CO;2-Z","article-title":"Mice Lacking NT-3, and Its Receptor TrkC, Exhibit Profound Deficiencies in CNS Glial Cells","volume":"26","author":"Kahn","year":"1999","journal-title":"Glia"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1101\/lm.76006","article-title":"NT-3 Facilitates Hippocampal Plasticity and Learning and Memory by Regulating Neurogenesis","volume":"13","author":"Shimazu","year":"2006","journal-title":"Learn. Mem."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0092-8674(00)81509-3","article-title":"BDNF Regulates the Maturation of Inhibition and the Critical Period of Plasticity in Mouse Visual Cortex","volume":"98","author":"Huang","year":"1999","journal-title":"Cell"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.nbd.2008.11.004","article-title":"Brain-Derived Neurotrophic Factor (BDNF) Overexpression in the Forebrain Results in Learning and Memory Impairments","volume":"33","author":"Cunha","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1471-4159.2007.05137.x","article-title":"Brain-Derived Neurotrophic Factor over-Expression in the Forebrain Ameliorates Huntington\u2019s Disease Phenotypes in Mice","volume":"105","author":"Gharami","year":"2008","journal-title":"J. Neurochem."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0306-4522(02)00301-9","article-title":"BDNF Overexpression Increases Dendrite Complexity in Hippocampal Dentate Gyrus","volume":"114","author":"Tolwani","year":"2002","journal-title":"Neuroscience"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/jnr.20181","article-title":"BDNF Overexpression Produces a Long-Term Increase in Myelin Formation in the Peripheral Nervous System","volume":"77","author":"Tolwani","year":"2004","journal-title":"J. Neurosci. Res."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"577406","DOI":"10.1016\/j.jneuroim.2020.577406","article-title":"The Emerging Role of the BDNF-TrkB Signaling Pathway in the Modulation of Pain Perception","volume":"349","author":"Cappoli","year":"2020","journal-title":"J. Neuroimmunol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41398-021-01280-3","article-title":"The Effect of Nerve Growth Factor on Supporting Spatial Memory Depends upon Hippocampal Cholinergic Innervation","volume":"11","author":"Eu","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"10657","DOI":"10.3390\/molecules200610657","article-title":"Neurotrophins and Neuropathic Pain: Role in Pathobiology","volume":"20","author":"Khan","year":"2015","journal-title":"Molecules"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1042\/CS20160044","article-title":"Neurotrophin Signalling: Novel Insights into Mechanisms and Pathophysiology","volume":"131","author":"Mitre","year":"2016","journal-title":"Clin. Sci."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1523\/JNEUROSCI.3792-05.2006","article-title":"Hippocampal Long-Term Potentiation Is Supported by Presynaptic and Postsynaptic Tyrosine Receptor Kinase B-Mediated Phospholipase C\u03b3 Signaling","volume":"26","author":"Polnau","year":"2006","journal-title":"J. Neurosci."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1523\/JNEUROSCI.1848-20.2021","article-title":"Adult TrkB Signaling in Parvalbumin Interneurons Is Essential to Prefrontal Network Dynamics","volume":"41","author":"Guyon","year":"2021","journal-title":"J. Neurosci."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1017\/S1461145710001008","article-title":"Higher BDNF Serum Levels Predict Slower Cognitive Decline in Alzheimer\u2019s Disease Patients","volume":"14","author":"Laske","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0169-328X(87)90044-1","article-title":"Decreased Level of Nerve Growth Factor (NGF) and Its Messenger RNA in the Aged Rat Brain","volume":"3","author":"Ebendal","year":"1987","journal-title":"Mol. Brain Res."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Numakawa, T., and Odaka, H. (2022). The Role of Neurotrophin Signaling in Age-Related Cognitive Decline and Cognitive Diseases. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23147726"},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Yang, T., Nie, Z., Shu, H., Kuang, Y., Chen, X., Cheng, J., Yu, S., and Liu, H. (2020). The Role of BDNF on Neural Plasticity in Depression. Front. Cell. Neurosci., 14.","DOI":"10.3389\/fncel.2020.00082"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Mosio\u0142ek, A., Mosio\u0142ek, J., Jakima, S., Pi\u0119ta, A., and Szulc, A. (2021). Effects of Antidepressant Treatment on Neurotrophic Factors (BDNF and IGF-1) in Patients with Major Depressive Disorder (MDD). J. Clin. Med., 10.","DOI":"10.3390\/jcm10153377"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41571-018-0113-0","article-title":"NTRK Fusion-Positive Cancers and TRK Inhibitor Therapy","volume":"15","author":"Cocco","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41698-021-00206-y","article-title":"Genomic Context of NTRK1\/2\/3 Fusion-Positive Tumours from a Large Real-World Population","volume":"5","author":"Westphalen","year":"2021","journal-title":"npj Precis. Oncol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000017069","article-title":"Intracerebroventricular Infusion of Nerve Growth Factor in Three Patients with Alzheimer\u2019s Disease","volume":"9","author":"Nordberg","year":"1998","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1179\/016164107X247948","article-title":"Intraventricular Nerve Growth Factor Infusion Improves Cerebral Blood Flow and Stimulates Doublecortin Expression in Two Infants with Hypoxic-Ischemic Brain Injury","volume":"30","author":"Chiaretti","year":"2008","journal-title":"Neurol. Res."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1080\/02699052.2017.1376760","article-title":"Intranasal Nerve Growth Factor Administration Improves Cerebral Functions in a Child with Severe Traumatic Brain Injury: A Case Report","volume":"31","author":"Chiaretti","year":"2017","journal-title":"Brain Inj."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nm1239","article-title":"A Phase 1 Clinical Trial of Nerve Growth Factor Gene Therapy for Alzheimer Disease","volume":"11","author":"Tuszynski","year":"2005","journal-title":"Nat. Med."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000336051","article-title":"Encapsulated Cell Biodelivery of Nerve Growth Factor to the Basal Forebrain in Patients with Alzheimer\u2019s Disease","volume":"33","author":"Linderoth","year":"2012","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jalz.2013.09.004","article-title":"A Phase1 Study of Stereotactic Gene Delivery of AAV2-NGF for Alzheimer\u2019s Disease","volume":"10","author":"Rafii","year":"2014","journal-title":"Alzheimers Dement."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1001\/jamaneurol.2018.0233","article-title":"Adeno-Associated Viral Vector (Serotype 2)\u2013Nerve Growth Factor for Patients with Alzheimer Disease: A Randomized Clinical Trial","volume":"75","author":"Rafii","year":"2018","journal-title":"JAMA Neurol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.jalz.2014.11.008","article-title":"Changes in CSF Cholinergic Biomarkers in Response to Cell Therapy with NGF in Patients with Alzheimer\u2019s Disease","volume":"11","author":"Karami","year":"2015","journal-title":"Alzheimers Dement."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1212\/WNL.52.7.1427","article-title":"A Controlled Trial of Recombinant Methionyl Human BDNF in ALS","volume":"52","author":"Group","year":"1999","journal-title":"Neurology"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1046\/j.1529-8027.2001.01019.x","article-title":"A Double-Blind Placebo-Controlled Clinical Trial of Recombinant Human Brain-Derived Neurotrophic Factor (RhBDNF) in Diabetic Polyneuropathy","volume":"6","author":"Wellmer","year":"2001","journal-title":"J. Peripher. Nerv. Syst."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1212\/01.WNL.0000171978.70849.c5","article-title":"NT-3 Promotes Nerve Regeneration and Sensory Improvement in CMT1A Mouse Models and in Patients","volume":"65","author":"Sahenk","year":"2005","journal-title":"Neurology"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/mt.2013.250","article-title":"AAV1.NT-3 Gene Therapy for Charcot\u2013Marie\u2013Tooth Neuropathy","volume":"22","author":"Sahenk","year":"2014","journal-title":"Mol. Ther."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/nbt.3028","article-title":"Allosteric Targeting of Receptor Tyrosine Kinases","volume":"32","author":"Smet","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"15258","DOI":"10.1021\/acs.jmedchem.0c01304","article-title":"Drug Development in Channelopathies: Allosteric Modulation of Ligand-Gated and Voltage-Gated Ion Channels","volume":"63","author":"Zhang","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"e1984","DOI":"10.1002\/hsr2.1984","article-title":"Review on Allosteric Modulators of Dopamine Receptors so Far","volume":"7","author":"Girmaw","year":"2024","journal-title":"Heal. Sci. Rep."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1021\/acs.jmedchem.8b00280","article-title":"Discovery of Allosteric, Potent, Subtype Selective, and Peripherally Restricted TrkA Kinase Inhibitors","volume":"62","author":"Bagal","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.bmcl.2017.01.056","article-title":"The Juxtamembrane Region of TrkA Kinase Is Critical for Inhibitor Selectivity","volume":"27","author":"Furuya","year":"2017","journal-title":"Bioorg Med. Chem. Lett."},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Hsiang, H.W., Girard, B.M., Ratkovits, L., Campbell, S.E., and Vizzard, M.A. (2022). Effects of Pharmacological Neurotrophin Receptor Inhibition on Bladder Function in Female Mice with Cyclophosphamide-Induced Cystitis. Front. Urol., 2.","DOI":"10.3389\/fruro.2022.1037511"},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Dahlstr\u00f6m, M., Madjid, N., Nordvall, G., Halldin, M.M., Vazquez-Juarez, E., Lindskog, M., Sandin, J., Winblad, B., Eriksdotter, M., and Forsell, P. (2021). Identification of Novel Positive Allosteric Modulators of Neurotrophin Receptors for the Treatment of Cognitive Dysfunction. Cells, 10.","DOI":"10.3390\/cells10081871"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"e051985","DOI":"10.1002\/alz.051985","article-title":"E2511, a Novel Small Compound TrkA Allosteric Modulator, Induces a Specific Trophic Signaling via Direct Binding to TrkA, and Can Reverse the Loss of Choline Acetyltransferase (ChAT) Positive Neurons in Transgenic Models of AD","volume":"17","author":"Tomioka","year":"2021","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s00702-005-0397-y","article-title":"Stage-Dependent BDNF Serum Concentrations in Alzheimer\u2019s Disease","volume":"113","author":"Laske","year":"2006","journal-title":"J. Neural Transm."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.neuropharm.2016.06.015","article-title":"A Small Molecule TrkB\/TrkC Neurotrophin Receptor Co-Activator with Distinctive Effects on Neuronal Survival and Process Outgrowth","volume":"110","author":"Yang","year":"2016","journal-title":"Neuropharmacology"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.cell.2021.01.034","article-title":"Antidepressant Drugs Act by Directly Binding to TRKB Neurotrophin Receptors","volume":"184","author":"Casarotto","year":"2021","journal-title":"Cell"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s41593-023-01316-5","article-title":"Psychedelics Promote Plasticity by Directly Binding to BDNF Receptor TrkB","volume":"26","author":"Moliner","year":"2023","journal-title":"Nat. Neurosci."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Fernandez, C.P., Juric, S., Backlund, M., Dahlstr\u00f6m, M., Madjid, N., Lidell, V., Rasti, A., Sandin, J., Nordvall, G., and Forsell, P. (2023). Neuroprotective and Disease-Modifying Effects of the Triazinetrione ACD856, a Positive Allosteric Modulator of Trk-Receptors for the Treatment of Cognitive Dysfunction in Alzheimer\u2019s Disease. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241311159"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"e062590","DOI":"10.1002\/alz.062590","article-title":"E2511, a Novel Small Compound TrkA Biased Positive Allosteric Modulator, Reinnervates Cholinergic Neuron via Enhancement of Specific Trophic Signaling of TrkA in Non-Clinical","volume":"19","author":"Tomioka","year":"2023","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"16329","DOI":"10.1073\/pnas.0706662104","article-title":"Gambogic Amide, a Selective Agonist for TrkA Receptor That Possesses Robust Neurotrophic Activity, Prevents Neuronal Cell Death","volume":"104","author":"Jang","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Jang, S.-W., Liu, X., Chan, C., France, S.A., Sayeed, I., Tang, W., Lin, X., Xiao, G., Andero, R., and Chang, Q. (2010). Deoxygedunin, a Natural Product with Potent Neurotrophic Activity in Mice. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0011528"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1073\/pnas.0913572107","article-title":"A Selective TrkB Agonist with Potent Neurotrophic Activities by 7,8-Dihydroxyflavone","volume":"107","author":"Jang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.exer.2011.06.014","article-title":"An NGF Mimetic, MIM-D3, Stimulates Conjunctival Cell Glycoconjugate Secretion and Demonstrates Therapeutic Efficacy in a Rat Model of Dry Eye","volume":"93","author":"Jain","year":"2011","journal-title":"Exp. Eye Res."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Yu, Z., Joy, S., Mi, T., Yazdanpanah, G., Burgess, K., and de Paiva, C.S. (2022). New, Potent, Small Molecule Agonists of Tyrosine Kinase Receptors Attenuate Dry Eye Disease. Front. Med., 9.","DOI":"10.3389\/fmed.2022.937142"},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Lazaridis, I., Charalampopoulos, I., Alexaki, V.-I., Avlonitis, N., Pediaditakis, I., Efstathopoulos, P., Calogeropoulou, T., Castanas, E., and Gravanis, A. (2011). Neurosteroid Dehydroepiandrosterone Interacts with Nerve Growth Factor (NGF) Receptors, Preventing Neuronal Apoptosis. PLoS Biol., 9.","DOI":"10.1371\/journal.pbio.1001051"},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Pediaditakis, I., Kourgiantaki, A., Prousis, K.C., Potamitis, C., Xanthopoulos, K.P., Zervou, M., Calogeropoulou, T., Charalampopoulos, I., and Gravanis, A. (2016). BNN27, a 17-Spiroepoxy Steroid Derivative, Interacts with and Activates P75 Neurotrophin Receptor, Rescuing Cerebellar Granule Neurons from Apoptosis. Front. Pharmacol., 7.","DOI":"10.3389\/fphar.2016.00512"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4103\/1673-5374.374138","article-title":"Are TrkB Receptor Agonists the Right Tool to Fulfill the Promises for a Therapeutic Value of the Brain-Derived Neurotrophic Factor?","volume":"19","author":"Zagrebelsky","year":"2023","journal-title":"Neural Regen. Res."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.neuropharm.2016.09.007","article-title":"Selective and Differential Interactions of BNN27, a Novel C17-Spiroepoxy Steroid Derivative, with TrkA Receptors, Regulating Neuronal Survival and Differentiation","volume":"111","author":"Pediaditakis","year":"2016","journal-title":"Neuropharmacology"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"113652","DOI":"10.1016\/j.expneurol.2021.113652","article-title":"Acute Treatment with TrkB Agonist LM22A-4 Confers Neuroprotection and Preserves Myelin Integrity in a Mouse Model of Pediatric Traumatic Brain Injury","volume":"339","author":"Fletcher","year":"2021","journal-title":"Exp. Neurol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1021\/acschemneuro.1c00181","article-title":"Optimized TrkB Agonist Ameliorates Alzheimer\u2019s Disease Pathologies and Improves Cognitive Functions via Inhibiting Delta-Secretase","volume":"12","author":"Chen","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s13287-024-03818-w","article-title":"Comprehensive Characterization of the Neurogenic and Neuroprotective Action of a Novel TrkB Agonist Using Mouse and Human Stem Cell Models of Alzheimer\u2019s Disease","volume":"15","author":"Charou","year":"2024","journal-title":"Stem Cell Res. Ther."},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Rogdakis, T., Charou, D., Latorrata, A., Papadimitriou, E., Tsengenes, A., Athanasiou, C., Papadopoulou, M., Chalikiopoulou, C., Katsila, T., and Ramos, I. (2022). Development and Biological Characterization of a Novel Selective TrkA Agonist with Neuroprotective Properties against Amyloid Toxicity. Biomedicines, 10.","DOI":"10.3390\/biomedicines10030614"},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Gonzalez, S., McHugh, T.L.M., Yang, T., Syriani, W., Massa, S.M., Longo, F.M., and Simmons, D.A. (2022). Small Molecule Modulation of TrkB and TrkC Neurotrophin Receptors Prevents Cholinergic Neuron Atrophy in an Alzheimer\u2019s Disease Mouse Model at an Advanced Pathological Stage. Neurobiol. Dis., 162.","DOI":"10.1016\/j.nbd.2021.105563"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1002\/alz.13857","article-title":"A TrkB and TrkC Partial Agonist Restores Deficits in Synaptic Function and Promotes Activity-dependent Synaptic and Microglial Transcriptomic Changes in a Late-stage Alzheimer\u2019s Mouse Model","volume":"20","author":"Yang","year":"2024","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Antonijevic, M., Charou, D., Davis, A., Curel, T., Valcarcel, M., Ramos, I., Villac\u00e9, P., Claeysen, S., Dallemagne, P., and Gravanis, A. (2024). Development of Pleiotropic TrkB and 5-HT4 Receptor Ligands as Neuroprotective Agents. Molecules, 29.","DOI":"10.3390\/molecules29020515"},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Todd, D., Gowers, I., Dowler, S.J., Wall, M.D., McAllister, G., Fischer, D.F., Dijkstra, S., Fratantoni, S.A., van de Bospoort, R., and Veenman-Koepke, J. (2014). A Monoclonal Antibody TrkB Receptor Agonist as a Potential Therapeutic for Huntington\u2019s Disease. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0087923"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"eaal1670","DOI":"10.1126\/scisignal.aal1670","article-title":"Multiplex Quantitative Assays Indicate a Need for Reevaluating Reported Small-Molecule TrkB Agonists","volume":"10","author":"Boltaev","year":"2017","journal-title":"Sci. Signal"},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Pankiewicz, P., Szybi\u0144ski, M., Kisielewska, K., Go\u0142\u0119biowski, F., Krzemi\u0144ski, P., Rutkowska-W\u0142odarczyk, I., Moszczy\u0144ski-P\u0119tkowski, R., Gurba-Bry\u015bkiewicz, L., Delis, M., and Mulewski, K. (2021). Do Small Molecules Activate the TrkB Receptor in the Same Manner as BDNF? Limitations of Published TrkB Low Molecular Agonists and Screening for Novel TrkB Orthosteric Agonists. Pharmaceuticals, 14.","DOI":"10.3390\/ph14080704"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neulet.2011.05.054","article-title":"Antioxidant Activity of 7,8-Dihydroxyflavone Provides Neuroprotection against Glutamate-Induced Toxicity","volume":"499","author":"Chen","year":"2011","journal-title":"Neurosci. Lett."},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Jakaria, M., Belaidi, A.A., Southon, A., Dent, K.A., Lane, D.J.R., Bush, A.I., and Ayton, S. (2022). Receptor-Independent Anti-Ferroptotic Activity of TrkB Modulators. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232416205"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"147844","DOI":"10.1016\/j.brainres.2022.147844","article-title":"The Antidepressant-like Effect of Formononetin on Chronic Corticosterone-Treated Mice","volume":"1783","author":"Zhang","year":"2022","journal-title":"Brain Res."},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Narducci, D., Charou, D., Rogdakis, T., Zota, I., Bafiti, V., Zervou, M., Katsila, T., Gravanis, A., Prousis, K.C., and Charalampopoulos, I. (2023). A Quest for the Stereo-Electronic Requirements for Selective Agonism for the Neurotrophin Receptors TrkA and TrkB in 17-Spirocyclic-Dehydroepiandrosterone Derivatives. Front. Mol. Neurosci., 16.","DOI":"10.3389\/fnmol.2023.1244133"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1038\/s41591-024-02977-w","article-title":"P75 Neurotrophin Receptor Modulation in Mild to Moderate Alzheimer Disease: A Randomized, Placebo-Controlled Phase 2a Trial","volume":"30","author":"Shanks","year":"2024","journal-title":"Nat. Med."},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Diniz, C.R.A.F., Crestani, A.P., Casarotto, P.C., Biojone, C., Cannarozzo, C., Winkel, F., Prozorov, M.A., Kot, E.F., Goncharuk, S.A., and Marques, D.B. (Biol. Psychiatry, 2024). Fluoxetine and Ketamine Trigger the P75NTR Proteolytic Pathway and Enhance Extinction Memory and Brain Plasticity through P75NTR, Biol. Psychiatry, in press.","DOI":"10.1016\/j.biopsych.2024.06.021"},{"key":"ref_170","unstructured":"Ohashi, Y., Norimine, Y., Hoshikawa, T., Yoshida, Y., Kobayashi, Y., Sato, N., and Hagiwara, K. (2019). Pentacyclic Compounds. (US10239889B1), U.S. Patent."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"e066208","DOI":"10.1002\/alz.066208","article-title":"First-in-Human (FIH), Single- and Multiple-Ascending-Dose (SAD\/MAD) Studies in Healthy Subjects of E2511, a Novel Tropomyosin Receptor Kinase a (TrkA) Positive Allosteric Modulator (PAM)","volume":"19","author":"Aceves","year":"2023","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_172","unstructured":"Nordvall, G., and Forsell, P. (2019). Triazine Derivatives for Treating Diseases Relating to Neurotrophins. (WO2019162702A1)."},{"key":"ref_173","unstructured":"Nordvall, G., and Forsell, P. (2019). 4-Substituted Phenyl-1,3,5-triazine Derivatives as Modulators of Trk Receptors. (WO2020002950A1)."},{"key":"ref_174","unstructured":"Nordvall, G., and Forsell, P. (2020). Triazine Derivatives for Treating Diseases Relating to Neurotrophins. (WO2021038241A1)."},{"key":"ref_175","unstructured":"Nordvall, G., and Forsell, P. (2019). 4-Substituted Phenyl-1,3,5-triazine Derivatives as Modulators of Trk Receptors. (WO2020002949A1)."},{"key":"ref_176","unstructured":"Nordvall, G., Forsell, P., and Sandin, J. (2017). Triazinetrione Derivatives and Their Use as Modulators of Neurotrophin Receptor and Receptor Tyrosine Kinases. (WO2018115891A1), 71p."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00228-024-03645-1","article-title":"ACD856, a Novel Positive Allosteric Modulator of Trk Receptors, Single Ascending Doses in Healthy Subjects: Safety and Pharmacokinetics","volume":"80","author":"Nilsson","year":"2024","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_178","first-page":"778","article-title":"Safety, Tolerability, Pharmacokinetics and Quantitative Electroencephalography Assessment of ACD856, a Novel Positive Allosteric Modulator of Trk-Receptors Following Multiple Doses in Healthy Subjects","volume":"10","author":"Nilsson","year":"2023","journal-title":"J. Prev. Alzheimer\u2019s Dis."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1021\/acsmedchemlett.9b00506","article-title":"Modulation of Tropomyosin Receptor Kinase for the Treatment of Neurotrophin Diseases: Alzheimer\u2019s, Huntington\u2019s and Parkinson\u2019s","volume":"10","author":"Kargbo","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"18430","DOI":"10.1073\/pnas.1115907108","article-title":"Self-Amplifying Autocrine Actions of BDNF in Axon Development","volume":"108","author":"Cheng","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.neuint.2015.10.009","article-title":"Self-Amplified BDNF Transcription Is a Regulatory System for Synaptic Maturation in Cultured Cortical Neurons","volume":"91","author":"Nakajima","year":"2015","journal-title":"Neurochem. Int."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1007\/s00213-023-06410-x","article-title":"Antidepressant Effects of Novel Positive Allosteric Modulators of Trk-Receptor Mediated Signaling\u2014A Potential Therapeutic Concept?","volume":"240","author":"Madjid","year":"2023","journal-title":"Psychopharmacology"},{"key":"ref_183","unstructured":"Saxena, S., Ye, Y., Sasaki, K., Kamakura, T., Ringheim, G., Giorgi, L., Penner, N., Horie, K., Devanarayan, V., and Sachdev, P. (2023, January 24\u201327). E2511, a Novel TrkA Modulator, Engages its CNS Cholinergic Target in a Phase 1 Clinical Study. Proceedings of the 16th Clinical Trials on Alzheimer\u2019s Disease (CTAD), Boston, MA, USA."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13195-020-00659-6","article-title":"Assessing What Matters Most to Patients with or at Risk for Alzheimer\u2019s and Care Partners: A Qualitative Study Evaluating Symptoms, Impacts, and Outcomes","volume":"12","author":"DiBenedetti","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"ref_185","doi-asserted-by":"crossref","unstructured":"Arosio, B., Guerini, F.R., Voshaar, R.C.O., and Aprahamian, I. (2021). Blood Brain-Derived Neurotrophic Factor (BDNF) and Major Depression: Do We Have a Translational Perspective?. Front. Behav. Neurosci., 15.","DOI":"10.3389\/fnbeh.2021.626906"},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Wang, Y., Li, O., Li, N., Sha, Z., Zhao, Z., and Xu, J. (2023). Association between the BDNF Val66Met Polymorphism and Major Depressive Disorder: A Systematic Review and Meta-Analysis. Front. Psychiatry, 14.","DOI":"10.3389\/fpsyt.2023.1143833"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.neulet.2013.12.051","article-title":"BDNF G196A (Val66Met) Polymorphism Associated with Cognitive Impairment in Parkinson\u2019s Disease","volume":"561","author":"Kurzawski","year":"2014","journal-title":"Neurosci. Lett."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0006-8993(00)02237-X","article-title":"Brain-Derived Neurotrophic Factor in Huntington Disease","volume":"866","author":"Ferrer","year":"2000","journal-title":"Brain Res."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jconrel.2023.11.007","article-title":"BDNF-Enriched Small Extracellular Vesicles Protect against Noise-Induced Hearing Loss in Mice","volume":"364","author":"Min","year":"2023","journal-title":"J. Control. Release"}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/17\/8\/997\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:25:24Z","timestamp":1760109924000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/17\/8\/997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,28]]},"references-count":189,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["ph17080997"],"URL":"https:\/\/doi.org\/10.3390\/ph17080997","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,28]]}}}